Literature DB >> 27842341

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions.

Sara Tognarelli1, Benedikt Jacobs2, Nina Staiger1, Evelyn Ullrich3.   

Abstract

Natural killer (NK) cells are an important part of the human tumor immune surveillance system. NK cells are able to distinguish between healthy and virus-infected or malignantly transformed cells due to a set of germline encoded inhibitory and activating receptors. Upon virus or tumor cell recognition a variety of different NK cell functions are initiated including cytotoxicity against the target cell as well as cytokine and chemokine production leading to the activation of other immune cells. It has been demonstrated that accurate NK cell functions are crucial for the treatment outcome of different virus infections and malignant diseases. Here a simple and reliable method is described to analyze different NK cell functions using a flow cytometry-based assay. NK cell functions can be evaluated not only for the whole NK cell population, but also for different NK cell subsets. This technique enables scientists to easily study NK cell functions in healthy donors or patients in order to reveal their impact on different malignancies and to further discover new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27842341      PMCID: PMC5226117          DOI: 10.3791/54615

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  37 in total

1.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

2.  Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.

Authors:  Ines Pires da Silva; Anne Gallois; Sonia Jimenez-Baranda; Shaukat Khan; Ana C Anderson; Vijay K Kuchroo; Iman Osman; Nina Bhardwaj
Journal:  Cancer Immunol Res       Date:  2014-02-11       Impact factor: 11.151

3.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

4.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Authors:  Niklas K Björkström; Peggy Riese; Frank Heuts; Sandra Andersson; Cyril Fauriat; Martin A Ivarsson; Andreas T Björklund; Malin Flodström-Tullberg; Jakob Michaëlsson; Martin E Rottenberg; Carlos A Guzmán; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

Review 5.  Immune Checkpoint Blockade in Cancer Therapy.

Authors:  Michael A Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

6.  A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.

Authors:  Liwei He; Jalil Hakimi; Danielle Salha; Ioana Miron; Pamela Dunn; Laszlo Radvanyi
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

7.  Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia.

Authors:  Emilie Laprevotte; Loïc Ysebaert; Christian Klein; Wilfried Valleron; Amandine Blanc; Emilie Gross; Guy Laurent; Jean-Jacques Fournié; Anne Quillet-Mary
Journal:  Leuk Res       Date:  2012-12-20       Impact factor: 3.156

8.  The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity.

Authors:  Julia Salih; Julia Hilpert; Theresa Placke; Frank Grünebach; Alexander Steinle; Helmut Rainer Salih; Matthias Krusch
Journal:  Int J Cancer       Date:  2010-11-01       Impact factor: 7.396

Review 9.  Advantages and applications of CAR-expressing natural killer cells.

Authors:  Wolfgang Glienke; Ruth Esser; Christoph Priesner; Julia D Suerth; Axel Schambach; Winfried S Wels; Manuel Grez; Stephan Kloess; Lubomir Arseniev; Ulrike Koehl
Journal:  Front Pharmacol       Date:  2015-02-12       Impact factor: 5.810

10.  NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation.

Authors:  Benedikt Jacobs; Sara Tognarelli; Kerstin Poller; Peter Bader; Andreas Mackensen; Evelyn Ullrich
Journal:  Front Immunol       Date:  2015-11-24       Impact factor: 7.561

View more
  5 in total

Review 1.  The role of automated cytometry in the new era of cancer immunotherapy.

Authors:  Marco Danova; Martina Torchio; Giuditta Comolli; Andrea Sbrana; Andrea Antonuzzo; Giuliano Mazzini
Journal:  Mol Clin Oncol       Date:  2018-08-20

2.  A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.

Authors:  Fadi Kandarian; Gemalene M Sunga; Diana Arango-Saenz; Maura Rossetti
Journal:  J Vis Exp       Date:  2017-08-09       Impact factor: 1.355

3.  Monitoring Natural Killer Cell Function in Human Ovarian Cancer Cells of Ascitic Fluid.

Authors:  Vikash Kumar; Asok Mukhopadhyay
Journal:  Bio Protoc       Date:  2018-12-20

4.  A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma.

Authors:  Juliane Wagner; Viktoria Pfannenstiel; Anja Waldmann; Judith W J Bergs; Boris Brill; Sabine Huenecke; Thomas Klingebiel; Franz Rödel; Christian J Buchholz; Winfried S Wels; Peter Bader; Evelyn Ullrich
Journal:  Front Immunol       Date:  2017-06-12       Impact factor: 7.561

5.  A novel CD2 staining-based flow cytometric assay for assessment of natural killer cell cytotoxicity.

Authors:  Dan Zhang; Rui Teng; Nan Lv; Lei Lei; Yanmeng Wang; Ramone A Williamson; Ping Chen; Peigen Gao; Michael O'Dwyer; Ang Li; Jinsong Hu
Journal:  J Clin Lab Anal       Date:  2020-08-17       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.